ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action

<p>SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between May 23, 2022 and May 10, 2023. ImmunityBio is a clinical-stage biotechnology company that develops therapies and vaccines that […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/immunitybio-inc-ibrx-investor-alert-robbins-llp-reminds-investors-of-lead-plaintiff-deadline-in-immunitybio-inc-class-action/">ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>